University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK.
J Rheumatol. 2011 Aug;38(8):1699-701. doi: 10.3899/jrheum.110388.
This overview draws out the main conclusions from the 4 workshops focused on incorporating the patient perspective into outcome assessment at the 10th Outcome Measures in Rheumatology (OMERACT 10) conference. They raised methodological issues about the choice of outcome domains to include in clinical trials, the development or choice of instruments to measure these domains, and the way these instruments might capture the impact of a disease and its treatment. The need to develop a more rigorous conceptual model of quantifying the way conditions affect health, and the need to ensure patients are directly involved in the decisions about domains and instruments, emerged clearly. The OMERACT participants voted to develop guidelines for domain and instrument selection, and conceptual and experimental work will be brought forward to revise and upgrade the OMERACT Filter.
这篇综述总结了第 10 届风湿病疗效测量学(OMERACT 10)会议上 4 场专注于将患者视角纳入疗效评估的专题研讨会的主要结论。它们提出了关于纳入临床试验的疗效评估领域选择、评估这些领域的工具的开发或选择以及这些工具如何捕捉疾病及其治疗的影响的方法学问题。显然,需要开发一种更严格的量化疾病影响健康方式的概念模型,并且需要确保患者直接参与关于领域和工具的决策。OMERACT 参与者投票决定制定疗效评估领域和工具选择的指南,并且将开展概念和实验工作来修订和升级 OMERACT 筛选器。